A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly developed antibody can restore immune responses in mice. Pancreatic cancer remains ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.

Sensitivity of primary hematopoietic tumors and tumor lines to the novel HDAC inhibitor PCI-24781 No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ...

Researchers have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells, that successfully reprogrammed the tumor immune microenvironment ...

Pancreatic cancer has a significantly poor prognosis; therefore, the development of effective treatments is an unmet clinical need. The major drawback in this field was the lack of useful model ...

Researchers have determined what affects lumen shape in pancreatic organoids, leading to the development of more accurate ...

Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the deadliest forms of cancer. “Effective treatment requires early detection.